CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
36.35
0.28%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 16:20

Mon - Fri: 08:00 - 16:20

  • Summary
  • Historical Data
Trading сonditions
Spread 0.30
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.01219 %
Charges from full value of position ($-2.32)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.01219%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010032 %
Charges from full value of position ($-1.91)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010032%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5.00%
Stock exchange Switzerland
Commission on trade 0%

Key Stats
Prev. Close 36.25
Open 36.1
1-Year Change -12.06%
Day's Range 35.75 - 36.35
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 36.25 0.40 1.12% 35.85 36.45 35.25
Dec 16, 2024 35.75 0.05 0.14% 35.70 35.90 35.25
Dec 13, 2024 35.70 -0.55 -1.52% 36.25 36.35 35.70
Dec 12, 2024 36.35 -0.55 -1.49% 36.90 37.05 36.15
Dec 11, 2024 36.85 -0.35 -0.94% 37.20 37.30 36.85
Dec 10, 2024 37.50 0.45 1.21% 37.05 37.65 36.85
Dec 9, 2024 37.30 -0.35 -0.93% 37.65 37.75 36.80
Dec 6, 2024 37.30 0.50 1.36% 36.80 37.65 36.80
Dec 5, 2024 37.40 0.70 1.91% 36.70 37.40 36.50
Dec 4, 2024 37.30 0.50 1.36% 36.80 37.45 36.80
Dec 3, 2024 37.10 -0.15 -0.40% 37.25 37.60 36.95
Dec 2, 2024 37.45 0.40 1.08% 37.05 37.70 36.60
Nov 29, 2024 37.10 -0.15 -0.40% 37.25 37.30 36.65
Nov 28, 2024 37.25 0.10 0.27% 37.15 37.40 36.95
Nov 27, 2024 37.05 0.15 0.41% 36.90 37.35 36.85
Nov 26, 2024 37.25 0.15 0.40% 37.10 37.55 36.15
Nov 25, 2024 37.25 0.85 2.34% 36.40 37.55 35.80
Nov 22, 2024 36.35 0.65 1.82% 35.70 36.40 35.25
Nov 21, 2024 35.90 0.20 0.56% 35.70 36.00 35.20
Nov 20, 2024 35.85 0.25 0.70% 35.60 36.10 35.20

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

BB Biotech Company profile

About BB BIOTECH AG

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, BB BIOTECH AG revenues decreased from SF741.8M to -SF343.6M. Net loss totaled SF404.8M vs. income of SF691.2M. Revenues reflect Unrealized Gains/Losses on Securities decrease from SF460.9M to -SF652.2M, Dividend Income decrease from SF243K to SF0K, Other income decrease of 83% to SF4K. Net loss reflects Management fees increase of 27% to SF50.7M (expense).

Equity composition

3/2016, 5-for-1 stock split (Factor: 5).

Industry: Biotechnology & Medical Research (NEC)

Schwertstrasse 6
SCHAFFHAUSEN
SCHAFFHAUSEN 8200
CH

People also watch

ETH/USD

3,876.25 Price
-1.380% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

22,073.10 Price
+0.400% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

2.57 Price
-1.620% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01280

BTC/USD

105,147.10 Price
-1.190% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading